Literature DB >> 28385197

Emergencies in Hematology and Oncology.

Thorvardur R Halfdanarson1, William J Hogan2, Bo E Madsen3.   

Abstract

The development of medical emergencies related to the underlying disease or as a result of complications of therapy are common in patients with hematologic or solid tumors. These oncological emergencies can occur as an initial presentation or in a patient with an established diagnosis and are encountered in all medical care settings, ranging from primary care to the emergency department and various subspecialty environments. Therefore, it is critically important that all physicians have a working knowledge of the potential oncological emergencies that may present in their practice and how to provide the most effective care without delay. This article reviews the most common oncological emergencies and provides practical guidance for initial management of these patients.
Copyright © 2017 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28385197     DOI: 10.1016/j.mayocp.2017.02.008

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  6 in total

Review 1.  Oncologic Emergencies-The Old, the New, and the Deadly.

Authors:  Krishna Thandra; Zuhair Salah; Sanjay Chawla
Journal:  J Intensive Care Med       Date:  2018-11-09       Impact factor: 3.510

2.  A Novel M6A-Related Genes Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma.

Authors:  Xuewen Wang; Chengfei Zhao; Dandan Huang; Zhoujie Liu; Mengmeng Liu; Fei Lin; Yingyu Lu; Jing Jia; Liqing Lin; Xinhua Lin; Huangyuan Li; Zhiwei Chen
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

3.  The role of specialized hospital units in infection and mortality risk reduction among patients with hematological cancers.

Authors:  Raïsa Carmen; Galit B Yom-Tov; Inneke Van Nieuwenhuyse; Bram Foubert; Yishai Ofran
Journal:  PLoS One       Date:  2019-03-20       Impact factor: 3.240

4.  Inorganic polyphosphate as an energy source in tumorigenesis.

Authors:  Jerusha Boyineni; Simone T Sredni; Naira V Margaryan; Lusine Demirkhanyan; Michael Tye; Robert Johnson; Fernando Gonzalez-Nilo; Mary J C Hendrix; Evgeny Pavlov; Marcelo B Soares; Eleonora Zakharian; Sergey Malchenko
Journal:  Oncotarget       Date:  2020-12-15

Review 5.  International consensus on radiotherapy in metastatic non-small cell lung cancer.

Authors:  Zhengfei Zhu; Jianjiao Ni; Xuwei Cai; Shengfa Su; Hongqing Zhuang; Zhenzhou Yang; Ming Chen; Shenglin Ma; Conghua Xie; Yaping Xu; Jiancheng Li; Hong Ge; Anwen Liu; Lujun Zhao; Chuangzhou Rao; Congying Xie; Nan Bi; Zhouguang Hui; Guangying Zhu; Zhiyong Yuan; Jun Wang; Lina Zhao; Wei Zhou; Chai Hong Rim; Arturo Navarro-Martin; Ben G L Vanneste; Dirk De Ruysscher; J Isabelle Choi; Jacek Jassem; Joe Y Chang; Lucyna Kepka; Lukas Käsmann; Michael T Milano; Paul Van Houtte; Rafal Suwinski; Alberto Traverso; Hiroshi Doi; Yang-Gun Suh; Georges Noël; Natsuo Tomita; Roman O Kowalchuk; Terence T Sio; Baosheng Li; Bing Lu; Xiaolong Fu
Journal:  Transl Lung Cancer Res       Date:  2022-09

Review 6.  Critically ill patients with cancer: A clinical perspective.

Authors:  Frank Daniel Martos-Benítez; Caridad de Dios Soler-Morejón; Karla Ximena Lara-Ponce; Versis Orama-Requejo; Dailé Burgos-Aragüez; Hilev Larrondo-Muguercia; Rahim W Lespoir
Journal:  World J Clin Oncol       Date:  2020-10-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.